FeaturedGeneticsNeurologyNeuroscienceOpen Neuroscience Articles·January 20, 2020·3 min readHuman Exposure to Aluminum Linked to Familial Alzheimer’s DiseaseResearchers found a close association between high aluminum content in brain tissue and amyloid-beta location in post-mortem samples of people with familial Alzheimer's disease. The findings back up previous claims that aluminum exposure may be linked to the development of the neurodegenerative disease.Read More
FeaturedNeurologyNeuroscience·January 16, 2020·3 min readAntipsychotics associated with increased risk of head & brain injuries in persons with Alzheimer’s diseaseAlzheimer's patients who used antipsychotics had a 29% increased risk of head injury and a 22% higher risk of TBI compared to others with the neurodegenerative disease who did not use the medications.Read More
FeaturedNeurologyNeuroscience·January 16, 2020·4 min readAre bigger brains better?Greater hippocampal volume is not always a reliable predictor of learning and memory ability in older adults. Faster learning was only found in older adults who had both greater hippocampal volume and more uniform white matter connections to other parts of the brain.Read More
FeaturedGeneticsNeurologyNeuroscience·January 15, 2020·3 min readInflammation a “game changer” as cellular death dance discoveredTNFR1 receptors arrange themselves into clusters, joining together trimers and making oligomers that create a pro-inflammatory response observed in a variety of diseases.Read More
Brain CancerFeaturedGeneticsNeurologyNeuroscienceOpen Neuroscience Articles·January 13, 2020·4 min readProtein associated with ovarian cancer exacerbates neurodegeneration in Alzheimer’sOCIAD1, a protein commonly associated with ovarian cancer, contributes to neurodegeneration in Alzheimer's disease by impairing mitochondrial function, leading to synaptic damage and neural vulnerability.Read More
ElectrophysiologyFeaturedGeneticsNeurologyNeuroscienceOpen Neuroscience Articles·January 12, 2020·4 min readNeurons’ energy organelle protected from damage linked to ALS & Alzheimer’sResearchers have identified a set of drug-like compounds, including a common ingredient in throat lozenges, that can help protect mitochondria from the stresses associated with neurodegenerative diseases.Read More
FeaturedNeurologyNeuroscience·January 11, 2020·4 min readLosing a night of sleep may increase blood levels of Alzheimer’s biomarkerFollowing a night of sleep deprivations, levels of tau in the blood increase 17% in healthy young men.Read More
AutismFeaturedGeneticsNeuroscience·January 9, 2020·3 min readMissing protein in brain causes behaviors mirroring autismp75NTR, a protein implicated in normal brain development and Alzheimer's disease, may play a role in the development of autism. Mice bred without the protein exhibited learning deficits similar to those associated with ASD.Read More
FeaturedNeurologyNeuroscience·January 8, 2020·3 min readAntipsychotic medications linked to brain injuries in individuals with Alzheimer’s diseasePeople with Alzheimer's disease who use antipsychotic medications have a 29% higher risk of head injury, and a 22% increased risk of TBI compared to those with the neurodegenerative disease who do not use the medications.Read More
FeaturedNeuroscience·January 2, 2020·2 min readEngrams emerging as the basic unit of memoryImaging and manipulating engrams at the cellular level provides important insights into memory function.Read More
FeaturedNeurologyNeuroscienceOpen Neuroscience Articles·January 2, 2020·3 min readExercise is good for your brain’s gray matterCardiorespiratory exercise improves gray matter volume in areas of the brain associated with age-related cognitive decline. The findings add weight to the previous studies which link physical activity to neuroprotection against age-related cognitive decline.Read More
FeaturedNeurologyNeuroscienceOpen Neuroscience Articles·December 31, 2019·4 min readPossible dementia vaccine closer after mice studiesClinical trials for a preventative treatment for dementia was successful in mouse models. Researchers say human trials will begin in two years.Read More